LIFE-BTK: Improving durability with bioresorbable technology
23
Speaking at TCT 2023 (23–26 October, San Francisco), vascular surgeon Ramon Varcoe (Sydney, Australia) reflects on the wider impact of the results of the LIFE-BTK trial on chronic limb-threatening ischaemia (CLTI) treatment.